Phase 1b study to assess the safety and tolerability of SR-878 in patients with rheumatoid arthritis

2025-523678-17-00 Protocol SR-878-01-002 Human pharmacology (Phase I) - Other Authorised, recruitment pending

Status Authorised, recruitment pending · 1 EU/EEA countries · 2 sites · Protocol SR-878-01-002

Overview

Sponsor-declared trial summary

Phase Human pharmacology (Phase I) - Other
Status Authorised, recruitment pending
Participants planned 27
Countries 1
Sites 2

rheumatoid arthritis

Key facts

Sponsor
SciRhom GmbH
Participant type
Patients
Age range
18-64 years
Gender
Male and Female
Therapeutic area
Diseases [C] - Immune System Diseases [C20]
Decision date (initial)
2026-04-24
Transition trial
No
Low-intervention
No
Rare-disease indication
No
Vulnerable population
Yes

External identifiers

EU CT number
2025-523678-17-00
WHO UTN
U1111-1328-2311

Trial design

CTIS Part I — objectives, methods, condition coding

Conditions and MedDRA coding

rheumatoid arthritis

VersionLevelCodeTermSystem organ class
23.1 PT 10039073 Rheumatoid arthritis 100000004859

Sponsors and contacts

Sponsor organisations, regulatory contacts, third parties

SciRhom GmbH

Sponsor organisation
SciRhom GmbH
Address
Am Klopferspitz 19, Martinsried Martinsried
City
Planegg
Postcode
82152
Country
Germany

Scientific contact point

Organisation
SciRhom GmbH
Contact name
Dr. Jürgen Reeß

Public contact point

Organisation
SciRhom GmbH
Contact name
Dr. Jürgen Reeß

Locations

1 EU/EEA country · 2 investigational sites

By country

CountryMS statusPlanned subjectsSites
Romania Authorised, recruitment pending 12 2
Rest of world
Moldova, Republic of, Georgia
15

Investigational sites

Romania

2 sites · Authorised, recruitment pending
Spitalul Clinic Judetean De Urgenta Cluj
Ophtalmology building, 1st floor, wards 33, 34, 35, Strada Clinicilor 3-5, 400006, Cluj-Napoca
Arensia Clinics S.R.L.
3rd floor, wards 1, 2, 3, 4, 5, 6 and 7, Intrarea Tudor Stefan 38-40, 011658, Bucharest

Application history

1 submissions — initial application plus substantial / non-substantial modifications

#TypeCodeSubmittedReference MSConclusionDecision date
1 INITIAL IN 2025-12-30 Romania Acceptable with conditions
2026-04-24
2026-04-24